Loading...
Sunday
April 19, 2020
Good evening,
Virgin Australia's board has retained control of the airline, but there's plenty of jostling among those keen to get their hands on the keys.
For advisers, it's the biggest ticket in town. Bankers, lawyers, accountants, insolvency types, you name it - Virgin is priority No.1.
Tonight, Street Talk can reveal one of the juicier mandates. It's one that has two of the biggest players in Australian dealmaking working side by side and, while it's only early days, they're sure to keep the situation interesting, should it open up for them.
Elsewhere, we look at the infrastructure funds taking a close look at Healthscope's pathology unit- yep, infrastructure considering a pathology acquisition - as well as raising candidate Challenger and copper play IGO.
Happy reading,
Sarah Thompson, Anthony Macdonald and Tim Boyd
Street Talk Editors
Street Talk
Virgin Australia's existing board and management are in control at the start of another week, but preparations are heating up for what happens next.
Blood tests are the new toll roads - just ask the infrastructure investors lining up for Healthscope's pathology unit.
When Challenger updates shareholders on its March quarter assets and funds under management, it'll be more exciting than your regular quarterly update.
Independence Group has made no secret of the fact it would be shopping for deals in 2020 with its $396 million war chest.
The daily habit of successful people
You have received this email because you are subscribed to Street Talk First Look with the email address: newsletter@newslettercollector.com
Manage Subscriptions Unsubscribe Privacy Policy Contact Us
© 2020 Australian Financial Review
38 - 42 Pirrama Rd Pyrmont, NSW 2009 Australia
© 2024